Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Sumapa Chaiamnuay"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Sarcopenia is linked to chronic inflammation and muscle wasting. This research aims to compare the screening accuracy of tools for sarcopenia in axial spondyloarthritis (axSpA). A cross-sectional study involving 104 axSpA patients was conduc
Externí odkaz:
https://doaj.org/article/82c14b0b3060462c8483a8b6505b11d6
Autor:
Pannarat Saisirivechakun, Ajanee Mahakkanukrauh, Chatlert Pongchaiyakul, Trirat Boonya-ussadorn, Pongthorn Narongroeknawin, Rattapol Pakchotanon, Paijit Assavatanabodee, Sumapa Chaiamnuay
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Axial spondyloarthritis (axSpA) increases the risk of osteoporosis and vertebral fractures. Bone mineral density (BMD) measured by dual X-ray absorptiometry (DXA) has limitations in axSpA patients. Trabecular bone score (TBS) indirectly asse
Externí odkaz:
https://doaj.org/article/d4b573288eda4bdb809f1fb2dc4135aa
Autor:
Natthinee Charatcharoenwitthaya, Unnop Jaisamrarn, Thawee Songpatanasilp, Vilai Kuptniratsaikul, Aasis Unnanuntana, Chanika Sritara, Hataikarn Nimitphong, Lalita Wattanachanya, Pojchong Chotiyarnwong, Tanawat Amphansap, Ong-Art Phruetthiphat, Thanut Valleenukul, Sumapa Chaiamnuay, Aisawan Petchlorlian, Varalak Srinonprasert, Sirakarn Tejavanija, Wasuwat Kitisomprayoonkul, Piyapat Dajpratham, Sukanya Chaikittisilpa, Woraluk Somboonporn
Publikováno v:
Osteoporosis and Sarcopenia, Vol 9, Iss 2, Pp 45-52 (2023)
Objectives: The Thai Osteoporosis Foundation (TOPF) is an academic organization that consists of a multidisciplinary group of healthcare professionals managing osteoporosis. The first clinical practice guideline for diagnosing and managing osteoporos
Externí odkaz:
https://doaj.org/article/a2e3cd4d9fee4530bdf73489c8eec05e
Publikováno v:
BMC Musculoskeletal Disorders, Vol 24, Iss 1, Pp 1-9 (2023)
Abstract Background Intra-articular (IA) corticosteroid injection is recommended in refractory knee osteoarthritis patients. However, 40-mg of triamcinolone IA every 3 months for 2 years reduces cartilage volume as compared to saline IA. Objective To
Externí odkaz:
https://doaj.org/article/89dd26390178423ea76efff98655c784
Autor:
Sumapa Chaiamnuay, Rattapol Pakchotanon, Pongthorn Narongroeknawin, Patamarwadee Chitpet, Paijit Asavatanabodee
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/2e6e71955029436fbe95995c527ee3f4
Autor:
Sumapa Chaiamnuay
Publikováno v:
Journal of Clinical Rheumatology and Immunology, Vol 22, Iss Supp01, Pp 31-39 (2022)
Recently, several updates in the assessment and treatment of postmenopausal osteoporosis guidelines were published. This review discusses international guidelines, including the algorithm for management of patients at risk of osteoporotic fracture fr
Externí odkaz:
https://doaj.org/article/319fff51dea24d39ae929cdedc21fba6
Glucocorticoid Withdrawal Symptoms and Quality of Life in Patients with Systemic Lupus Erythematosus
Autor:
Matee Karoonkatima, Pongthorn Narongroeknawin, Sumapa Chaiamnuay, Paijit Asavatanabodee, Rattapol Pakchotanon
Publikováno v:
International Journal of Rheumatology, Vol 2023 (2023)
Background/Objective. Chronic glucocorticoid (GCS) therapy is associated with increased risk of organ damage in systemic lupus erythematosus (SLE). However, discontinuation of low-dose GCS might cause withdrawal symptoms. This study is aimed at ident
Externí odkaz:
https://doaj.org/article/2ca2070b112d4c0a9032810e41ff09f7
Publikováno v:
Bone Reports, Vol 16, Iss , Pp 101153- (2022)
Background: Zoledronate 5 mg intravenous (IV) annually is approved for treatment of post-menopausal osteoporosis. Zoledronate 4 mg which is approved for the treatment of cancer related hypercalcemia can be an alternative for Asian women who have smal
Externí odkaz:
https://doaj.org/article/8c4ab97ae0e34df0b019b8ffb7db4297
Publikováno v:
BMC Rheumatology, Vol 3, Iss 1, Pp 1-10 (2019)
Abstract Background Group B Streptococcus (GBS) emerged as the frequent pathogen for septic arthritis. There was no study comparing risks, clinical presentations and outcomes between GBS septic arthritis and other bacterial septic arthritis. The aim
Externí odkaz:
https://doaj.org/article/1dd2cf21769447209ce952012ef9255e
Autor:
Pornsawan Leosuthamas, Pongthorn Narongroeknawin, Sumapa Chaiamnuay, Paijit Asavatanabodee, Rattapol Pakchotanon
Publikováno v:
International Journal of Rheumatic Diseases. 26:667-672